New six months HIV Injectables cost Shs 100 million
The United States Food and Drug Administration (FDA) has approved long-acting injectable lenacapavir for HIV prevention. The new medicine is administered by injection once every six months and is a significant step in improving prevention options for people at risk of HIV infection around the world. In an interview, Gilead
